Wolfram Schmidt

President, Head of Europe · Biogen

Biotechnology

Wolfram Schmidt is Biogen’s president and head of Europe, with earlier pharmaceutical leadership at Roche, MSD and Boehringer Ingelheim.

Last reviewed: Nov 2, 2026

Wolfram Schmidt

President, Head of Europe
Biogen

Last Reviewed: November 2, 2026

Executive Summary

Wolfram Schmidt is Biogen’s president and head of Europe, with earlier pharmaceutical leadership at Roche, MSD and Boehringer Ingelheim.

Career Highlights

  • Joined Biogen in 2018 as managing director of its German business.
  • Previously held leadership roles at Roche, MSD and Boehringer Ingelheim.
  • Serves on EFPIA’s board and the supervisory board of neuroscience company a:head.

Professional Journey

Schmidt trained in chemistry at Ulm University and the University of Bayreuth. His pharmaceutical career included leadership positions at Boehringer Ingelheim, Merck Sharp & Dohme and Roche, with work in both the United States and Europe.

He joined Biogen in 2018 as managing director of Biogen Germany, the company’s largest subsidiary outside the United States. By 2022, Biogen identified him as president for Europe, Canada and Partner Markets in its European corporate materials.

Schmidt now serves as president and head of Europe and belongs to Biogen’s extended leadership team. Alongside his company responsibilities, he is a board member of the European Federation of Pharmaceutical Industries and Associations.

His earlier industry association work included the presidency of American Biotechnology Companies Germany and executive board service at Germany’s Association of Research-Based Pharmaceutical Companies. He also sits on the supervisory board of a:head, an Austrian neuroscience company working with stem cells and brain organoids.

Education

Schmidt holds a master’s degree in chemistry from Ulm University and a Ph.D. in chemistry from the University of Bayreuth.